Valerio Therapeutics Société anonyme (ALVIO.PA)
EUR 0.08
(3.31%)
EUR 0.08
(3.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.8 Million | 1.44 Million | 4.06 Million | 1.77 Million | 4.28 Million | 6.12 Million |
| Cost of Revenue | 533 Thousand | 514 Thousand | 368 Thousand | 1.94 Million | 350 Thousand | 215 Thousand |
| Gross Profit | 1.26 Million | 929 Thousand | 3.69 Million | -166 Thousand | 3.93 Million | 5.91 Million |
| Operating Expenses | 20.32 Million | 18.04 Million | 9.26 Million | 9.24 Million | 19.73 Million | 21.55 Million |
| Selling, General and Administrative Expenses | 2.61 Million | 2.63 Million | 2.33 Million | 2.41 Million | 2.96 Million | 5.71 Million |
| Research and Development Expenses | 9.67 Million | 7.87 Million | 3.05 Million | 2.1 Million | 5.84 Million | 4.92 Million |
| Other Expenses | 8.03 Million | 389 Thousand | -581 Thousand | 10 Million | -243 Thousand | 5.43 Million |
| Cost and Expenses | 20.85 Million | 18.55 Million | 9.63 Million | 11.18 Million | 20.08 Million | 21.77 Million |
| Operating Income | -20.28 Million | -17.11 Million | -5.58 Million | -7.81 Million | -9.79 Million | -15.64 Million |
| Interest Expense | 66 Thousand | 2.18 Million | 1.69 Million | 959 Thousand | 1.03 Million | 1.03 Million |
| Income Tax Expense | 17 Thousand | 285 Thousand | 100 Thousand | 757 Thousand | -2.32 Million | -1.76 Million |
| Earnings before Tax | -20.32 Million | -19.27 Million | -6.66 Million | 1.84 Million | -36.05 Million | -11.15 Million |
| Net Income | -20.34 Million | -19.56 Million | -5.93 Million | 1.08 Million | -33.72 Million | -9.39 Million |
| Earnings Per Share Basic | -0.15 | -0.18 | -0.07 | 0.01 | -0.55 | -0.18 |
| Earnings Per Share Diluted | -0.15 | -0.18 | -0.07 | 0.01 | -0.55 | -0.18 |
| Weighted Average Shares Outstanding | 135.62 Million | 105.74 Million | 88.21 Million | 73.15 Million | 61.37 Million | 53.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 135.62 Million | 105.74 Million | 88.21 Million | 75.86 Million | 61.37 Million | 53.61 Million |
| Gross Margin | 0.70 | 0.64 | 0.91 | -0.09 | 0.92 | 0.96 |
| EBIT Margin | -10.51 | -11.84 | -1.21 | -4.61 | 1.72 | -0.15 |
| Profit Margin | -11.30 | -13.56 | -1.46 | 0.61 | -7.87 | -1.53 |
| EBITDA | -18.91 Million | -17.03 Million | -4.89 Million | 2.33 Million | -35.66 Million | -946 Thousand |
| Earnings Before Tax Margin | -11.27 | -11.86 | -1.37 | -4.40 | -2.28 | -2.55 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 44.5 Thousand | 44.5 Thousand | 900 Thousand | 1.8 Million | 900 Thousand | - |
| Cost of Revenue | 81.5 Thousand | 81.5 Thousand | 157 Thousand | 533 Thousand | 157 Thousand | 125 Thousand |
| Gross Profit | -37 Thousand | -37 Thousand | 743 Thousand | 1.26 Million | 743 Thousand | -125 Thousand |
| Operating Expenses | 5.42 Million | 5.42 Million | 5.1 Million | 20.37 Million | 5.1 Million | 12.22 Million |
| Selling, General and Administrative Expenses | 4.48 Million | 4.48 Million | 4.21 Million | - | 4.21 Million | 5.84 Million |
| Research and Development Expenses | 4.36 Million | - | 2.82 Million | - | 2.82 Million | 6.24 Million |
| Other Expenses | 939.5 Thousand | 939.5 Thousand | -147 Thousand | 153 Thousand | - | -127 Thousand |
| Cost and Expenses | 5.5 Million | 5.5 Million | 5.26 Million | 20.85 Million | 5.26 Million | 12.34 Million |
| Operating Income | -5.46 Million | -5.46 Million | -3.72 Million | -19.05 Million | -3.72 Million | -12.34 Million |
| Interest Expense | 60 Thousand | - | - | 138 Thousand | - | 88 Thousand |
| Income Tax Expense | -700 Thousand | - | 8500.00 | 17 Thousand | 8500.00 | -750 Thousand |
| Earnings before Tax | -5.47 Million | -5.47 Million | -4.34 Million | -20.32 Million | -4.34 Million | -12.39 Million |
| Net Income | -5.47 Million | -5.47 Million | -4.35 Million | -20.34 Million | -4.35 Million | -11.64 Million |
| Earnings Per Share Basic | -0.03 | -0.03 | -0.03 | - | -0.03 | -0.10 |
| Earnings Per Share Diluted | -0.03 | -0.03 | -0.03 | - | -0.03 | -0.10 |
| Weighted Average Shares Outstanding | 163.93 Million | 163.93 Million | 154.22 Million | 135.62 Million | 154.22 Million | 116.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 163.93 Million | 163.93 Million | 154.22 Million | 135.62 Million | 154.22 Million | 116.19 Million |
| Gross Margin | -0.83 | -0.83 | 0.83 | 0.70 | 0.83 | - |
| EBIT Margin | -105.92 | -105.92 | -4.03 | - | -4.03 | - |
| Profit Margin | -123.12 | -123.12 | -4.83 | -11.30 | -4.83 | - |
| EBITDA | -4.71 Million | -4.71 Million | -3.63 Million | - | -3.63 Million | -12.22 Million |
| Earnings Before Tax Margin | -122.75 | -122.75 | -4.14 | -10.58 | -4.14 | - |
9220
JMPLY
6805
601788
ROI
BAJFINANCE